Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cure rate after 131I therapy for hyperthyroidism.

L E Holm, G Lundell, I Dahlqvist

    Acta Radiologica. Oncology
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Shifting from an individual to an organizational perspective in work environment management - a process evaluation of a six-year intervention program within the Swedish public sector.

    BMC public health·2023
    Same author

    High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome.

    The British journal of ophthalmology·2014
    Same author

    Dose response of xylitol and sorbitol for EPR retrospective dosimetry with applications to chewing gum.

    Radiation protection dosimetry·2012
    Same author

    Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer.

    British journal of cancer·2012
    Same author

    Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR.

    British journal of cancer·2006
    Same author

    Predictors of outcome in patients with papillary thyroid carcinoma.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2006

    The cure rate for hyperthyroidism using radioactive iodine (131I) therapy improved significantly over two decades. This study analyzed 4,473 patients, showing increased cure rates for both diffuse and nodular thyroid conditions over time.

    Area of Science:

    • Endocrinology
    • Nuclear Medicine
    • Thyroidology

    Background:

    • Hyperthyroidism is a common endocrine disorder.
    • Radioactive iodine (131I) therapy is a standard treatment for hyperthyroidism.
    • Long-term outcomes of 131I therapy require continuous evaluation.

    Purpose of the Study:

    • To analyze the cure rate of hyperthyroidism following 131I therapy.
    • To assess trends in treatment efficacy over a 25-year period (1951-1975).
    • To compare cure rates between diffuse and nodular thyroid gland presentations.

    Main Methods:

    • Retrospective analysis of 4,473 hyperthyroidism patients treated between 1951 and 1975.
    • Categorization of patients based on thyroid gland morphology (diffuse vs. nodular).

    Related Experiment Videos

  • Evaluation of cure rates within the first 4 months post-therapy, stratified by 5-year treatment periods.

    • Main Results:

    • A notable increase in the cumulative incidence of cure was observed across successive 5-year periods.
    • For diffuse thyroid glands, the 4-month cure rate rose from 34% (1951-1955) to 59% (1971-1975), a 1.7-fold increase.
    • For nodular thyroid glands, the 4-month cure rate improved from 23% (1951-1955) to 54% (1971-1975), a 2.3-fold increase.

    Conclusions:

    • Radioactive iodine therapy for hyperthyroidism demonstrated improving cure rates over the study period.
    • Treatment principles remained consistent, suggesting enhanced outcomes may relate to evolving patient management or diagnostic criteria.
    • The efficacy of 131I therapy has significantly increased for both diffuse and nodular hyperthyroidism.